Search

Ramesh B Batchu

from Detroit, MI
Age ~63
Get Report
Also known as:
Ramesh Babu Batchu, Ramesh-Babu Batchu, Rameshbabu Batchu, Batchu Ramesh Babu, Batchu R Babu, Batchu B Ramesh, Batchu Ramesh-Babu, Ramesh U
Phone and address:
180 Marina Ct UNIT 83, Detroit, MI 48214
Related to:
Venkatta ChikkamSreenivas Batchu
Connected to:
Pavan K Batchu, 59Prabhakar Batchu, 66Prathima Batchu, 47Srinivasa Batchu, 50Surya K Batchu, 55Anna P Batchvarova, 52Blanka Batchvarov, 62Daniel K Batchvarov, 43Denitza L Batchvarova, 41Aaron L Batdorf, 51

Ramesh Batchu Phones & Addresses

  • 180 Marina Ct UNIT 83, Detroit, MI 48214
  • 4821 Woodland Ave, Royal Oak, MI 48073 (248) 435-4129
  • Troy, MI
  • 101 Engamore Ln, Norwood, MA 02062 (781) 762-8239
  • 301 Engamore Ln, Norwood, MA 02062 (781) 762-8239
  • 101 Wickham Way, Norwood, MA 02062 (781) 762-8239
  • Westwood, MA
  • Little Rock, AR

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ramesh Babu Batchu
President
ONE LOVE INC
301 Engamore Ln T3 Norwood Ma 02062 Usa<Br/>301 Engamore Ln T3, Norwood, MA 02062

Publications

Us Patents

Adeno-Associated Virus 2/8 - Micro Rna-101 Therapy For Liver Cancer

View page
US Patent:
20130267582, Oct 10, 2013
Filed:
Feb 22, 2011
Appl. No.:
13/580552
Inventors:
Koteswara Rao Kollipara - Hyderabad, IN
Ramesh Babu Batchu - Royal Oak MI, US
International Classification:
C12N 15/861
US Classification:
514 44 R, 4353201, 435370
Abstract:
Adeno-associated virus 2/8-microRNA-101(AAV2/8-miR-101) therapy for liver cancer is provided. In particular, the invention provides a recombinant AAV 2/8 vector, comprising mutated capsid, for the enforced expression of pre-miR-101 and for the treatment of liver cancer.

Antibody For Targeted Induction Of Apoptosis, Cdc And Adcc Mediated Killing Of Cancer Cells, Tbl-Cln1

View page
US Patent:
20120027763, Feb 2, 2012
Filed:
Mar 4, 2011
Appl. No.:
13/041203
Inventors:
Koteswara Rao KOLLIPARA - Hyderabad, IN
Ramesh Babu BATCHU - Royal Oak MI, US
Assignee:
TRANSGENE BIOTEK LTD. - Medak District
International Classification:
C07K 16/30
A61K 39/395
A61P 35/04
G01N 33/566
US Classification:
4241381, 436501, 530326, 5303877, 5303873
Abstract:
Antibody for targeted induction of Apoptosis, CDC and ADCC mediated killing of Cancer cells, TBL-CLN1, is disclosed. The antibodies, TBL-CLN1, are monoclonal antibodies which can specifically target and bind to the epitope of SEQ ID NO:1 expressed on cancer cells which further leads to killing of cancer cells. TBL-CLN1 is not conjugated to toxin or cytotoxic molecules, and provides selective killing of cancer cells just by binding to cancer cell surface. Also, disclosed herein is SEQ ID NO: 2 which is an engineered epitope which comprises of polypeptide sequence of SEQ ID NO: 1 and a cysteine residue which is added at the carboxyl end of the SEQ ID NO: 1. The epitope of SEQ ID NO: 2 is used to generate monoclonal antibodies described herein.
Control profile
Ramesh B Batchu from Detroit, MI, age ~63 Get Report